Inogen, Inc. (INGN) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Inogen, Inc. (INGN) closed at USD 6.30 on 2026-10-15, a change of -25.1 % over the past year, with a market capitalization of USD 165.86M.

Inogen, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Inogen, Inc. key figures

Previous close

USD 6.30 (2026-10-15)

1-year change

-25.1 %

Market cap

USD 165.86M

Enterprise value

USD 76.12M

P/E ratio (trailing)

-6.79

P/E ratio (forward)

-39.06

EPS (trailing)

-0.92

EPS (forward)

-0.16

PEG ratio

n/a

Price to book

0.96

Revenue growth

3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.32

Employees

753

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Inogen, Inc.

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Inogen, Inc. and compare it with other stocks.